While women with NF1 over 50 years of age do not differ significantly in breast cancer risk compared to women in the general population (Evans, 2012; Uusitalo et al., 2016), those younger than 50 years have an up to five-fold increased risk (Maani et al., 2019). Here, NF1 is linked to breast carcinoma.